-
New York, drug distributors reach $1.18 billion opioid settlement as national deal looms
expresspharma
July 22, 2021
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
-
Regeneron to invest $1.8bn to expand facilities in New York
pharmaceutical-technology
July 19, 2021
Regeneron Pharmaceuticals has plans to invest nearly $1.8bn to boost research, preclinical production and support sites at its Westchester County campus in Tarrytown, New York, US.
-
New York State to Ban Flavored E-Cigarettes
drugs
September 17, 2019
Using his executive powers, New York Governor Andrew Cuomo has ordered a ban on most flavored electronic cigarettes in the state.
-
Officials Say New York City Measles Outbreak Over
drugs
September 04, 2019
The New York City measles outbreak is over and the public health emergency that was declared on April 9 for parts of Brooklyn has ended, New York Mayor Bill de Blasio said Tuesday.
-
Regeneron plots $800M New York production push—along with 1,500 new jobs
fiercepharma
August 15, 2019
Regeneron is humming along on the strength of flagship eye med Eylea and fast-launching immunology drug Dupixent. Now, the drugmaker is investing $800 million in its New York operations to keep up with the growth.
-
New York State Halts Religious Vaccine Exemption
drugs
June 17, 2019
New York State Halts Religious Vaccine Exemption.
-
Breathe Easier, New York City: Clean-Air Taxi Rules Are Working
drugs
May 30, 2019
Clean-air taxi rules in New York City increased cabs' fuel efficiency and reduced air pollution, a new study says.
-
New York City Measles Cases Increase to 390
drugs
April 25, 2019
The number of measles cases in New York City has risen to 390, the health department said Wednesday.
-
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
pharmafocusasia
September 29, 2018
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointment of Robert J. Mi
-
Regeneron continues New York expansion with $800M project, 1,500 jobs
fiercepharma
September 14, 2018
Regeneron is supersizing a campus expansion in New York, investing $800 million and adding 1,500 jobs and winning a substantial tax break in the process.